Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Costs and benefits of long-term psychoanalytic therapy: changes in health care use and work impairment.

de Maat S, Philipszoon F, Schoevers R, Dekker J, De Jonghe F.

Harv Rev Psychiatry. 2007 Nov-Dec;15(6):289-300. Review.

PMID:
18097839
3.

Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.

Ruof J, Hülsemann JL, Mittendorf T, Handelmann S, von der Schulenburg JM, Zeidler H, Merkesdal S.

Ann Rheum Dis. 2003 Jun;62(6):544-9.

4.

The effects of long-term psychoanalytic treatment on healthcare utilization and work impairment and their associated costs.

Berghout CC, Zevalkink J, Hakkaart-Van Roijen L.

J Psychiatr Pract. 2010 Jul;16(4):209-16. doi: 10.1097/01.pra.0000386907.99536.75.

PMID:
20644356
5.

Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.

Schädlich PK, Zeidler H, Zink A, Gromnica-Ihle E, Schneider M, Straub C, Brecht JG, Huppertz E.

Pharmacoeconomics. 2005;23(4):377-93.

PMID:
15853437
6.

Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.

Olivares JM, Rodriguez-Martinez A, Burón JA, Alonso-Escolano D, Rodriguez-Morales A; e-STAR Study Group.

Appl Health Econ Health Policy. 2008;6(1):41-53.

PMID:
18774869
7.

Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).

Hallert E, Husberg M, Jonsson D, Skogh T.

Rheumatology (Oxford). 2004 Nov;43(11):1374-82. Epub 2004 Jul 27.

PMID:
15280570
8.

Effectiveness of short-term and long-term psychotherapy on work ability and functional capacity--a randomized clinical trial on depressive and anxiety disorders.

Knekt P, Lindfors O, Laaksonen MA, Raitasalo R, Haaramo P, Järvikoski A; Helsinki Psychotherapy Study Group.

J Affect Disord. 2008 Apr;107(1-3):95-106. Epub 2007 Sep 5.

PMID:
17804079
9.

Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

Boonen A, van der Heijde D, Landewé R, Spoorenberg A, Schouten H, Rutten-van Mölken M, Guillemin F, Dougados M, Mielants H, de Vlam K, van der Tempel H, van der Linden S.

Ann Rheum Dis. 2002 May;61(5):429-37.

10.

Health costs in anthroposophic therapy users: a two-year prospective cohort study.

Hamre HJ, Witt CM, Glockmann A, Ziegler R, Willich SN, Kiene H.

BMC Health Serv Res. 2006 Jun 2;6:65.

11.

The effectiveness of long-term psychoanalytic therapy: a systematic review of empirical studies.

de Maat S, de Jonghe F, Schoevers R, Dekker J.

Harv Rev Psychiatry. 2009;17(1):1-23. doi: 10.1080/10673220902742476. Review.

PMID:
19205963
12.

Sick leave reductions from a comprehensive manual therapy programme for low back pain: the Gotland Low Back Pain Study.

Bogefeldt J, Grunnesjö MI, Svärdsudd K, Blomberg S.

Clin Rehabil. 2008 Jun;22(6):529-41. doi: 10.1177/0269215507087294.

PMID:
18511533
13.

Costs and quality of life for patients with multiple sclerosis in Belgium.

Kobelt G.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S24-33.

PMID:
17318662
14.

Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project).

Hallert E, Husberg M, Skogh T.

Rheumatology (Oxford). 2006 Mar;45(3):325-31. Epub 2005 Nov 15.

PMID:
16287927
15.

Cost effectiveness of two rehabilitation programmes for neck and back pain patients: A seven year follow-up.

Jensen IB, Busch H, Bodin L, Hagberg J, Nygren A, Bergström G.

Pain. 2009 Apr;142(3):202-8. doi: 10.1016/j.pain.2008.12.015. Epub 2009 Feb 13.

PMID:
19217717
16.

[Cost of illness in Alzheimer's disease].

Kiencke P, Rychlik R, Grimm C, Daniel D.

Med Klin (Munich). 2010 May;105(5):327-33. doi: 10.1007/s00063-010-1060-4. Epub 2010 May 26. German.

PMID:
20503006
17.

The direct and indirect costs of the chronic management of osteoporosis: a prospective follow-up of 3440 active subjects.

Rabenda V, Manette C, Lemmens R, Mariani AM, Struvay N, Reginster JY.

Osteoporos Int. 2006;17(9):1346-52. Epub 2006 Jun 24.

PMID:
16799755
18.

A 3-year follow-up of a multidisciplinary rehabilitation programme for back and neck pain.

Jensen IB, Bergström G, Ljungquist T, Bodin L.

Pain. 2005 Jun;115(3):273-83. Epub 2005 Apr 19.

PMID:
15911154
19.

[Health and drug consumption profile in Cameroon].

Commeyras C, Ndo JR, Merabet O, Kone H, Rakotondrabe FP.

Sante. 2006 Jan-Mar;16(1):13-9. French.

20.

Burden and cost of illness in patients with juvenile idiopathic arthritis.

Minden K, Niewerth M, Listing J, Biedermann T, Schöntube M, Zink A.

Ann Rheum Dis. 2004 Jul;63(7):836-42.

Supplemental Content

Support Center